Company intelligence / Profile preview

MTI Biotech

Ames, Iowa, United Statesmtibiotech.com ↗

Ownership: Private
Development stage: Other

Overview

MTI Biotech is best known for developing HMB, a nutritional ingredient with proven safety and efficacy in muscle health. The company has also advanced a small molecule therapeutic, 2-hydroxybenzylamine (2-HOBA), into proof-of-concept and biomarker studies in early Alzheimer’s patients. Preclinical and short-term human safety have been demonstrated for 2-HOBA; long-term safety and cognitive benefit are under evaluation.

Therapeutic areas: NeurologyOther
Modalities: Small moleculeNutritional supplement ingredient (e.g., HMB)
Industry: Biotech

Partnerships

Heartland Assays LLCAcademic collaborations with major research universities

Beyond the preview

Go deeper on MTI Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTI Biotech.

Explore the full profile